Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Katsunori Imazumi"'
Antiemetic Activity of FK1052, a 5-HT3- and 5-HT4-Receptor Antagonist, in Suncus murinus and Ferrets
Autor:
Hiroe Nakayama, Hisashi Yamakuni, Mika Higaki, Hirofumi Ishikawa, Katsunori Imazumi, Masahiko Matsuo, Seitaro Mutoh
Publikováno v:
Journal of Pharmacological Sciences, Vol 98, Iss 4, Pp 396-403 (2005)
We investigated the effect of FK1052 [(+)-8,9-dihydro-10-methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]pyrido[1,2-a]indol-6(7H)-one hydrochloride], a 5-HT3- and 5-HT4-receptor antagonist, on the emesis induced by motion stimuli, copper sulfate, or cisp
Externí odkaz:
https://doaj.org/article/9c01ee585e994c918725eef19bc59a92
Autor:
Hiroe Nakayama, Hisashi Yamakuni, Aya Nakayama, Yasue Maeda, Katsunori Imazumi, Masahiko Matsuo, Seitaro Mutoh
Publikováno v:
Journal of Pharmacological Sciences, Vol 96, Iss 3, Pp 301-306 (2004)
Previous studies showed that diphenidol was effective on emetogens-induced pica, eating of non-nutritive substances, in rats, a model analogous to emesis in other species. We evaluated the actual antiemetic activity of diphenidol against four emetic
Externí odkaz:
https://doaj.org/article/ddec576f7c7d4b43ab62f20d43181b8e
Autor:
Risa Okimoto, Katsutoshi Ino, Kenichiro Ishizu, Hajime Takamatsu, Kazuyuki Sakamoto, Hironori Yuyama, Katsunori Imazumi, Akiyoshi Ohtake, Noriyuki Masuda, Masahiro Takeda
Publikováno v:
LUTS: Lower Urinary Tract Symptoms. 14:289-300
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3657b7019a9a403cc949799dde92b5c8
https://doi.org/10.1111/luts.12430
https://doi.org/10.1111/luts.12430
Autor:
Risa, Okimoto, Katsutoshi, Ino, Kenichiro, Ishizu, Hajime, Takamatsu, Kazuyuki, Sakamoto, Hironori, Yuyama, Katsunori, Imazumi, Akiyoshi, Ohtake, Noriyuki, Masuda, Masahiro, Takeda
Publikováno v:
Lower urinary tract symptomsREFERENCES. 14(4)
Muscarinic MModulation of carbachol-induced increases in intracellular CaASP8302 demonstrated PAM effects on the rat MOur results in rats indicate that ASP8302 improves voiding dysfunction by potentiating bladder contraction with fewer effects on cho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dcb958fe54ec727e1785a997e9f350a4
https://pubmed.ncbi.nlm.nih.gov/35150075
https://pubmed.ncbi.nlm.nih.gov/35150075
Autor:
Akiyoshi Ohtake, Katsunori Imazumi, Noriyuki Masuda, Yukiko Noguchi, Masahiro Takeda, Kazuyuki Sakamoto, Koji Ueshima
Publikováno v:
European Journal of Pharmacology. 847:83-90
Current pharmacotherapies for voiding dysfunctions are in need of improvement. Lysophosphatidic acid (LPA) is a phospholipid that contracts the urethra by activating type 1 LPA receptors (LPA1). However, the role of LPA1 in regulating urethral tonus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ad267104b5536b982b253806012f86
https://doi.org/10.1016/j.ejphar.2019.01.014
https://doi.org/10.1016/j.ejphar.2019.01.014
Autor:
Hisashi, Yamakuni 1, #1, *, Hiroe, Nakayama 1, #2, Shigeo, Matsui 1, #1, Katsunori, Imazumi 1, #1, Masahiko, Matsuo 1, #1, Seitaro, Mutoh 1, #1
Publikováno v:
In Journal of Pharmacological Sciences 2006 101(1):99-102
Autor:
Masahiro Takeda, Yukiko Noguchi, Koji Ueshima, Shuichi Sato, Akiyoshi Ohtake, Kazuyuki Sakamoto, Noriyuki Masuda, Katsunori Imazumi
Publikováno v:
European journal of pharmacology. 853
Bladder dysfunctions associated with benign prostatic hyperplasia are not sufficiently alleviated by current pharmacotherapies. Lysophosphatidic acid (LPA) is a phospholipid with diverse biological effects. LPA modulates prostate and urethral contrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::913b41d76f9aa63cbda0d4d0d9491fbd
https://pubmed.ncbi.nlm.nih.gov/30853531
https://pubmed.ncbi.nlm.nih.gov/30853531
Autor:
Kazuyuki Sakamoto, Koji Ueshima, Yukiko Noguchi, Katsunori Imazumi, Masahiro Takeda, Akiyoshi Ohtake, Noriyuki Masuda
Publikováno v:
Journal of Urology. 199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a25e4ce4423d3c4881356c5c2fff9fd
https://doi.org/10.1016/j.juro.2018.02.327
https://doi.org/10.1016/j.juro.2018.02.327
Autor:
Hajime Takamatsu, Taiji Yoshino, Ryoko Kurihara, Katsunori Imazumi, Kenichiro Ishizu, Noriyuki Masuda
Publikováno v:
LUTS: Lower Urinary Tract Symptoms. 8:130-135
Objectives We investigated the effect of the selective prostaglandin E2 EP2 receptor agonist CP-533,536 on voiding efficiency in rats with midodrine-induced functional urethral obstruction. Methods The effect of CP-533,536 (0.03–0.3 mg/kg, intraven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d86fdad629baae81a01b60be4eddde0a
https://doi.org/10.1111/luts.12080
https://doi.org/10.1111/luts.12080
Autor:
Shigeo Matsui, Seitaro Mutoh, Katsunori Imazumi, Masahiko Matsuo, Hisashi Yamakuni, Hiroe Nakayama
Publikováno v:
Journal of Pharmacological Sciences, Vol 101, Iss 1, Pp 99-102 (2006)
We evaluated the antiemetic effect of zacopride, a potent 5-HT3-receptor antagonist with 5-HT4-receptor agonist properties, on delayed emesis caused by cisplatin (5 mg/kg, i.p.) in ferrets, compared with granisetron, a selective 5-HT3-receptor antago
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f19eaeaeef6f426ca4c7951f5724d19c
http://www.sciencedirect.com/science/article/pii/S1347861319344809
http://www.sciencedirect.com/science/article/pii/S1347861319344809